The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions
Open accessAbstract
High levels of familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 mutants G93A and G37R were previously shown to mediate disease in mice through an acquired toxic property. We report here that even low levels of another mutant, G85R, cause motor neuron disease characterized by an extremely rapid clinical progression, without changes in SOD1 activity. Initial indicators of disease are astrocytic inclusions that stain intensely with SOD1 antibodies and ubiquitin and SOD1-containing aggregates in motor neurons, features common with some cases of SOD1 mutant-mediated ALS. Astrocytic inclusions escalate markedly as disease progresses, concomitant with a decrease in the glial glutamate transporter (GLT-1). Thus, the G85R SOD1 mutant mediates direct damage to astrocytes, which may promote the nearly synchronous degeneration of motor neurons.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“implying that astrocytes are both necessary and sufficient for neurodegeneration in this ALS model.”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [414]
In the citing paper
“Selective clearance of SOD1-positive inclusions from astrocytes is sufficient to slow disease progression [414]”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [414]
In the citing paper
“In transgenic mice overexpressing mutant SOD1 associated with ALS, astrocytes display more SOD1-positive inclusions than do neurons, and at an earlier stage [414].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [414]
Citations
Cites
Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels
Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
Halliwell, B. B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,926
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Self-citationCellular defenses against damage from reactive oxygen species
Yu, B. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.1.139 · Cited by 2,382
Localization of neuronal and glial glutamate transporters
Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703
Self-citationAmyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase
Deng, H., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,479
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,000
Xu, L., Shen, P., Hazel, T. G., Johe, K. K., & Koliatsos, V. E. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.017 · Cited by 90
Watanabe, S., Ageta‐Ishihara, N., Nagatsu, S., Takao, K., Komine, O., Endo, F., Miyakawa, T., Misawa, H., Takahashi, R., Kinoshita, M., et al. (2014) · Molecular Brain · doi:10.1186/s13041-014-0062-1 · Cited by 90
Amyotrophic lateral sclerosis: update and new developments
Perry, J. J. P., Pratt, A. J., & Getzoff (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s19803 · Cited by 94
Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis
Bidhendi, E. E., Bergh, J., Zetterström, P., Forsberg, K., Pakkenberg, B., Andersen, P. M., Marklund, S. L., & Brännström, T. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1915-y · Cited by 89
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases
Dhib-Jalbut, S. S., Arnold, D. L., Cleveland, D. W., Fisher, M., Friedlander, R. M., Mouradian, M. M., Przedborski, S., Trapp, B. D., Wyss‐Coray, T., & Yong, V. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.027 · Cited by 91
Self-citationMutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease
Fil, D., DeLoach, A., Yadav, S., Alkam, D., MacNicol, M. C., Singh, A., Compadre, C. M., Goellner, J. J., O’Brien, C. A., Fahmi, T., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw429 · Cited by 88
Lack of behavioral and neuropathological effects of dietary β-methylamino-l-alanine (BMAA) in mice
Cruz-Aguado, R., Winkler, D., & Shaw, C. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.012 · Cited by 88
The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis
Wright, G. S. A., Antonyuk, S. V., & Hasnain, S. S. (2019) · Quarterly Reviews of Biophysics · doi:10.1017/s003358351900012x · Cited by 87
Shaw, B. F., Lelie, H., Durazo, A., Nersissian, A. M., Xu, G., Chan, P. K., Gralla, E. B., Tiwari, A., Hayward, L. J., Borchelt, D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707751200 · Cited by 88
Self-citationHedlund, E., Karlsson, M., Osborn, T. M., Ludwig, W. W., & Ole Isacson, A. (2010) · Brain · doi:10.1093/brain/awq167 · Cited by 93
Morrison, B. M., & Morrison, J. H. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00049-6 · Cited by 88
Expression of mutant SOD1 G93A in astrocytes induces functional deficits in motoneuron mitochondria
Bilsland, L. G., Nirmalananthan, N., Yip, J., Greensmith, L., & Duchen, M. R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05699.x · Cited by 88
Realistic Prospects for Stem Cell Therapeutics
Daley, G. Q., Goodell, M. A., & Snyder, E. Y. (2003) · Hematology · doi:10.1182/asheducation-2003.1.398 · Cited by 89
Fendrick, S. E., Xue, Q., & Streit, W. J. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-9 · Cited by 88
Le, N. T. T., Chang, L., Kovlyagina, I., Georgiou, P., Safren, N., Braunstein, K. E., Kvarta, M. D., Dyke, A. M. V., LeGates, T. A., Philips, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608432113 · Cited by 96
Self-citationA Novel Action of Histone Deacetylase Inhibitors in a Protein Aggresome Disease Model
Corcoran, L., Mitchison, T. J., & Liu, Q. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.003 · Cited by 87
The multifaceted role of glial cells in amyotrophic lateral sclerosis
Valori, C. F., Brambilla, L., Martorana, F., & Rossi, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1429-7 · Cited by 88
Wang, J., Xu, G. M., & Borchelt, D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03642.x · Cited by 87
Self-citationOf mice and men: Reconciling preclinical ALS mouse studies and human clinical trials
Rothstein, J. D. (2003) · Annals of Neurology · doi:10.1002/ana.10561 · Cited by 86
Self-citationStructural and biophysical properties of metal-free pathogenic SOD1 mutants A4V and G93A
Galaleldeen, A., Strange, R. W., Whitson, L. J., Antonyuk, S. V., Narayana, N., Taylor, A. B., Schuermann, J. P., Holloway, S. P., Hasnain, S. S., & Hart, P. J. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.09.020 · Cited by 84
The neurobiology of amyotrophic lateral sclerosis
Bento‐Abreu, A., Damme, P. V., Bosch, L. V. D., & Robberecht, W. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07260.x · Cited by 89
Taylor, D. M., Gibbs, B. F., Kabashi, E., Minotti, S., Durham, H. D., & Agar, J. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610119200 · Cited by 85
Tokuda, E., Okawa, E., Watanabe, S., Ono, S.-I., & Marklund, S. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.001 · Cited by 83
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice
Schilling, G., Savonenko, A. V., Coonfield, M. L., Morton, J. L., Vorovich, E. B., Gale, A., Neslon, C., Chan, N., Eaton, M., Fromholt, D., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.003 · Cited by 85
Self-citationExtensive exercise is not harmful in amyotrophic lateral sclerosis
Liebetanz, D., Hagemann, K., von Lewinski, F., Kahler, E., & Paulus, W. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03769.x · Cited by 85
Translational Control of Glial Glutamate Transporter EAAT2 Expression
Tian, G., Lai, L., Guo, H., Lin, Y., Butchbach, M. E. R., Chang, Y., & Lin, C. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609822200 · Cited by 85
Gong, Y. H., & Elliott, J. L. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7323 · Cited by 85
Facchinetti, F., Sasaki, M., Cutting, F. B., Macdonald, J. E., Reif, D. W., Beal, M. F., Huang, P. L., Dawson, T. M., Gurney, M. E., Dawson, V. L., et al. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00492-8 · Cited by 85
Tudor, E. L., Galtrey, C. M., Perkinton, M. S., Lau, K., Vos, K. J. D., Mitchell, J. C., Ackerley, S., Hortobágyi, T., Vámos, E., Leigh, P. N., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.035 · Cited by 90
Ciccarelli, R., D’Alimonte, I., Ballerini, P., D’Auro, M., Nargi, E., Buccella, S., Iorio, P. D., Bruno, V., Nicoletti, F., & Caciagli, F. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031617 · Cited by 84
Nagano, S., Fujii, Y., Yamamoto, T., Taniyama, M., Fukada, K., Yanagihara, T., & Sakoda, S. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00014-6 · Cited by 83
Stieber, A., Gonatas, J. O., & Gonatas, N. K. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00351-8 · Cited by 76
Aebischer, J., Cassina, P., Otsmane, B., Moumen, A., Seilhean, D., Meininger, V., Barbeito, L., Pettmann, B., & Raoul, C. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.143 · Cited by 83
The role of excitotoxicity in ALS - what is the evidence?
Ludolph, A. C., Meyer, T., & Riepe, M. W. (2000) · Journal of Neurology · doi:10.1007/s004150050552 · Cited by 84
Tradewell, M. L., Cooper, L. A., Minotti, S., & Durham, H. D. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.016 · Cited by 81
Mulligan, V. K., & Chakrabartty, A. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24285 · Cited by 81
Lobsiger, C. S., Garcia, M. L., Ward, C. M., & Cleveland, D. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503862102 · Cited by 81
Self-citationCardoso, R. M. F., THAYER, M. M., DiDonato, M., Lo, T. P., Bruns, C. K., Getzoff, E. D., & Tainer, J. A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01090-2 · Cited by 81
Menzies, F. M., Grierson, A. J., Cookson, M., Heath, P. R., Tomkins, J., Figlewicz, D. A., Ince, P. G., & Shaw, P. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01045.x · Cited by 81
Chou, S. M., Wang, H. S., Taniguchi, A., & Bucala, R. (1998) · Molecular Medicine · doi:10.1007/bf03401739 · Cited by 81
Nagai, M., Abe, K., Okamoto, K., & Itoyama, Y. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00158-x · Cited by 81
Tiwari, A., Liba, A., Sohn, S. H., Seetharaman, S. V., Bilsel, O., Matthews, C. R., Hart, P. J., Valentine, J. S., & Hayward, L. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.043729 · Cited by 80
Leyton-Jaimes, M. F., Kahn, J., & Israelson, A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.021 · Cited by 80
Duan, W., Guo, M., Yi, L., Liu, Y., Li, Z., Ma, Y., Zhang, G., Liu, Y., Bu, H., Song, X., et al. (2019) · Gene Therapy · doi:10.1038/s41434-019-0116-1 · Cited by 79
Synphilin-1 is present in Lewy bodies in Parkinson's disease
Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 269
Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity
Watanabe, S., Hayakawa, T., Wakasugi, K., & Yamanaka, K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.459 · Cited by 81
Ingram, D. K., & Jucker, M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00033-0 · Cited by 80
From molecule to molecule and cell to cell: Prion-like mechanisms in amyotrophic lateral sclerosis
Grad, L. I., Fernando, S. M., & Cashman, N. R. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.009 · Cited by 80
Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis
Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666170622095802 · Cited by 84
Maurel, C., Dangoumau, A., Marouillat, S., Brulard, C., Chami, A. A., Hergesheimer, R. C., Corcia, P., Blasco, H., Andres, C. R., & Vourc’h, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0856-0 · Cited by 82
Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of Norrin
Miller, S., Philips, T., Kim, N., Dastgheyb, R. M., Chen, Z., Hsieh, Y.-C., Daigle, J. G., Datta, M. S., Chew, J., Vidensky, S., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0366-7 · Cited by 78
Self-citationPeterson, A. R., & Binder, D. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00164 · Cited by 82
Avossa, D., Grandolfo, M., Mazzarol, F., Zatta, M., & Ballerini, L. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.009 · Cited by 78
Sandelin, E., Nordlund, A., Andersen, P. M., Marklund, S. L., & Oliveberg, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700765200 · Cited by 78
Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes
Pratt, A. J., Shin, D. S., Merz, G. E., Rambo, R. P., Lancaster, W. A., Dyer, K. N., Borbat, P. P., Poole, F. L., Adams, M. W. W., Freed, J. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308531111 · Cited by 80
Lelek, J., & Zuba‐Surma, E. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030799 · Cited by 76
Bonifacino, T., Zerbo, R. A., Balbi, M., Torazza, C., Frumento, G., Fedele, E., Bonanno, G., & Milanese, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212236 · Cited by 82
Oxidative stress and antioxidant enzyme upregulation in SOD1‐G93A mouse skeletal muscle
Mahoney, D. J., Kaczor, J. J., Bourgeois, J. M., Yasuda, N., & Tarnopolsky, M. A. (2006) · Muscle & Nerve · doi:10.1002/mus.20542 · Cited by 80
Amendola, J., & Durand, J. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21818 · Cited by 77
Spalloni, A., Albo, F., Ferrari, F., Mercuri, N. B., Bernardi, G., Zona, C., & Longone, P. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.012 · Cited by 77
Calcium: the Darth Vader of ALS
Appel, S. H., Beers, D. R., Siklós, L., Engelhardt, J., & Mosier, D. R. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201300079418 · Cited by 88
Progressive spinal axonal degeneration and slowness in ALS2‐deficient mice
Yamanaka, K., Miller, T. M., McAlonis‐Downes, M., Chun, S. J., & Cleveland, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20888 · Cited by 77
Self-citationPuttaparthi, K., Wójcik, C., Rajendran, B., Demartino, G., & Elliott, J. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02028.x · Cited by 77
MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis
Wu, C., Watts, M. E., & Rubin, L. L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.019 · Cited by 78
Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping
Bergh, J., Zetterström, P., Andersen, P. M., Brännström, T., Graffmo, K. S., Jonsson, P., Lang, L., Danielsson, J., Oliveberg, M., & Marklund, S. L. (2015) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1419228112 · Cited by 78
Tokuda, E., Ono, S.-I., Ishige, K., Naganuma, A., Ito, Y., & Suzuki, T. (2006) · Toxicology · doi:10.1016/j.tox.2006.09.011 · Cited by 76
Stieber, A., Gonatas, J. O., & Gonatas, N. K. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00300-7 · Cited by 76
Gerber, Y. N., Sabourin, J.-C., Rábano, M., Vivanco, M. D., & Perrin, F. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036000 · Cited by 76
Intracellular Pathways of Copper Trafficking in Yeast and Humans
Culotta, V., Lin, S.-J., Schmidt, P. J., Klomp, L. W. J., Casareno, R. L. B., & Gitlin, J. D. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4859-1_22 · Cited by 76
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 76
Shaw, B. F., Durazo, A., Nersissian, A. M., Whitelegge, J. P., Faull, K. F., & Valentine, J. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600623200 · Cited by 74
Trumbull, K. A., & Beckman, J. S. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2574 · Cited by 79
PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43
Joardar, A., Menzl, J., Podolsky, T. C., Manzo, E., Estes, P. S., Ashford, S., & Zarnescu, D. C. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu587 · Cited by 76
TGFβ Trophic Factors Differentially Modulate Motor Axon Outgrowth and Protection from Excitotoxicity
Ho, T. W., Bristol, L. A., Coccia, C., Li, Y., Milbrandt, J., Johnson, E. M., Jin, L., Bar-Peled, O., Griffin, J. W., & Rothstein, J. D. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7290 · Cited by 75
Self-citationGonatas, N. K., Gonatas, J. O., & Stieber, A. (1998) · Histochemistry and Cell Biology · doi:10.1007/s004180050257 · Cited by 75
Autophagy in Astrocytes and its Implications in Neurodegeneration
Sung, K., & Jiménez-Sánchez, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.041 · Cited by 78
Kiaei, M., Kipiani, K., Petri, S., Choi, D., Chen, J., Calingasan, N. Y., & Beal, M. F. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03024.x · Cited by 74
Wang, H., Ying, Z., & Wang, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299990 · Cited by 77
Provenzano, F., Torazza, C., Bonifacino, T., Bonanno, G., & Milanese, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015430 · Cited by 78
Strong, M. J. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001505 · Cited by 73
Lentiviral vectors for treating and modeling human CNS disorders
Azzouz, M., Kingsman, S. M., & Mazarakis, N. D. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.600 · Cited by 71
The Neuroprotective Factor Wlds Does Not Attenuate Mutant SOD1-Mediated Motor Neuron Disease
Velde, C. V., Garcia, M. L., Yin, X., Trapp, B. D., & Cleveland, D. W. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:3:193 · Cited by 77
Self-citationSnyder, E. Y., Daley, G. Q., & Goodell, M. A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20033 · Cited by 72
Gill, C., Phelan, J. P., Hatzipetros, T., Kidd, J. D., Tassinari, V. R., Levine, B. A., Wang, M. Z., Moreno, A., Thompson, K., Maier, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43164-z · Cited by 78
Sasaki, S., Warita, H., Abe, K., & Iwata, M. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1021-9 · Cited by 72
Kato, S., Horiuchi, S., Liu, J., Cleveland, D. W., Shibata, N., Nakashima, K., Nagai, R., Hirano, A., Takikawa, M., Kato, M., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010000226 · Cited by 72
Self-citationRapid disease progression correlates with instability of mutant SOD1 in familial ALS
Sato, T., Nakanishi, T., Yamamoto, Y., Andersen, P. M., Ogawa, Y., Fukada, K., Zhou, Z., Aoike, F., Sugai, F., Nagano, S., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000188760.53922.05 · Cited by 72
The genetic and molecular mechanisms of motor neuron disease
Wong, P. C., Rothstein, J. D., & Price, D. L. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80123-2 · Cited by 72
Self-citationTan, H. Y., Yong, Y. K., Xue, Y. C., Liu, H., Furihata, T., Shankar, E. M., & Ng, C. S. (2022) · iScience · doi:10.1016/j.isci.2022.104404 · Cited by 73
Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS
Lladó, J., Haenggeli, C., Pardo, A. C., Wong, V., Benson, L. M., Coccia, C., Rothstein, J. D., Shefner, J. M., & Maragakis, N. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.019 · Cited by 71
Self-citationSunico, C. R., Domínguez-Vías, G., García‐Verdugo, J. M., Osta, R., Montero, F., & Moreno‐López, B. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00417.x · Cited by 79
Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease?
Neusch, C., Bähr, M., & Schneider‐Gold, C. (2007) · Muscle & Nerve · doi:10.1002/mus.20768 · Cited by 69
Transglutaminase 2 in neurodegenerative disorders
Ruan, Q. (2006) · Frontiers in bioscience · doi:10.2741/2111 · Cited by 71
Rumfeldt, J., Stathopulos, P. B., Chakrabarrty, A., Lepock, J. R., & Meiering, E. M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.042 · Cited by 70
Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients
Iłżecka, J. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00102.x · Cited by 70
Prion-like activity of Cu/Zn superoxide dismutase
Grad, L. I., & Cashman, N. R. (2014) · Prion · doi:10.4161/pri.27602 · Cited by 69
Vargas, M. R., Johnson, D. A., & Johnson, J. A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.025 · Cited by 70
Turner, B. J., Ackerley, S., Davies, K. E., & Talbot, K. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp550 · Cited by 69
Tortarolo, M., Crossthwaite, A. J., Conforti, L., Spencer, J. P. E., Williams, R. J., Bendotti, C., & Rattray, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02208.x · Cited by 69
FTD and ALS—translating mouse studies into clinical trials
Ittner, L. M., Halliday, G. M., Kril, J. J., Götz, J., Hodges, J. R., & Kiernan, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.65 · Cited by 70
Metadata
- Authors
- Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., & Cleveland, D. W.
- Affiliations
- University of California San Diego (US)
- Johns Hopkins University (US)
- National Cancer Institute (US)
- Corresponding author
- Cleveland, D.W.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 18
- Issue
- 2
- Pages
- 327-338
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2012851706
- Cited by
- 1,341
- References
- 39
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 23 · 2023: 30 · 2022: 41 · 2021: 40 · 2020: 36 · 2019: 35 · 2018: 36 · 2017: 40 · 2016: 47 · 2015: 44 · 2014: 52 · 2013: 52 · 2012: 64
- FWCI
- 37.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neuron (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- National Institute on Aging (P50AG005146, AG 05146)
- National Institute of Neurological Disorders and Stroke (NS10580, NS 27036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, SOD1 G93A, astrocyte damage, motor neuron degeneration, disease progression, glutamate transporter GLT-1, ubiquitin, familial ALS
- MeSH terms
- Amyotrophic Lateral Sclerosis, Animals, Astrocytes, Axons, Disease Models, Animal, Genes, Dominant, Humans, Mice, Transgenic, Microscopy, Electron, Nerve Degeneration, Neurons, Spinal Cord, Superoxide Dismutase, Ubiquitins, Point Mutation, ATP-Binding Cassette Transporters, Amino Acid Transport System X-AG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review